Wordt geladen...
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
INTRODUCTION: Curcumin is a polyphenolic compound derived from the plant Curcuma Long Lin that has been demonstrated to have antioxidant and anti-inflammatory effects as well as effects on reducing beta-amyloid aggregation. It reduces pathology in transgenic models of Alzheimer's disease (AD) a...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3580400/ https://ncbi.nlm.nih.gov/pubmed/23107780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt146 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|